Article Details

NTAGI may soon review efficacy data of India's first intranasal Covid vaccine

Retrieved on: 2022-06-01 20:47:57

Tags for this article:

Click the tags to see associated articles and topics

NTAGI may soon review efficacy data of India's first intranasal Covid vaccine. View article details on HISWAI: https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/ntagi-may-soon-review-efficacy-data-of-indias-first-intranasal-covid-vaccine/articleshow/91948882.cms

Excerpt

... conduct standalone phase III trials on its Covid-19 intranasal vaccine. The company also received approval to evaluate the intranasal vaccine, ...

Article found on: economictimes.indiatimes.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up